参考文献/References:
[1]刘早玲,唐溢乐,苏津,等.代谢综合征患者糖化白蛋白及糖化血红蛋白比值与全因死亡率的关系[J].现代预防医学,2024,51(23):4225-4230.
[2]岳悦,郑桂玲,褚月颉,等.四逆散合平胃散联合罗格列酮治疗代谢综合征疗效及对患者氧自由基水平的影响[J].陕西中医,2022,43(4):479-482.
[3]张玉红,宋凤莲,陈勇.利司那肽联合贝那普利对代谢综合征患者血糖血压、肠道微生态、靶器官损害的影响[J].临床误诊误治,2023,36(10):96-100.
[4]GONZLEZ GONZLEZ J G,VIOLANTE CUMPA J R,ZAMBRANO LUCIO M,et al.HOMA-IR as a predictor of health outcomes in patients with metabolic risk factors:A systematic review and meta-analysis[J].High Blood Press Cardiovasc Prev,2022,29(6):547-564.
[5]武凯璐,温爱纯,王晓静,等.2型糖尿病合并代谢综合征患者健康问题解决类型研究[J].护理学杂志,2024,39(23):8-13.
[6]SCARPIGNATO C,HUNT R H.Potassium-competitive acid blockers:Current clinical use and future developments[J].Curr Gastroenterol Rep,2024,26(11):273-293.
[7]中国医师协会中西医结合医师分会内分泌与代谢病学专业委员会.代谢综合征病证结合诊疗指南[J].世界中医药,2023,18(22):3157-3166.
[8]GARRIDO TORRES N,ROCHA GONZALEZ I,ALAMEDA L,et al.Metabolic syndrome in antipsychotic-nave patients with first-episode psychosis:A systematic review and meta-analysis[J].Psychol Med,2021,51(14):2307-2320.
[9]张琳,郭珊岚,康乐平.胃癌组织MutS同源物6、减数分裂后分离增强基因2表达与幽门螺杆菌感染及预后相关性研究[J].陕西医学杂志,2025,54(3):408-412.
[10]BELLADELLI F,MONTORSI F,MARTINI A.Metabolic syndrome,obesity and cancer risk[J].Curr Opin Urol,2022,32(6):594-597.
[11]KOUNTOURAS J,ZAVOS C,VARDAKA E,et al.Helicobacter pylori and metabolic syndrome-related adipokines in nonalcoholic fatty liver disease pathophysiology[J].J Gastroenterol Hepatol,2024,39(9):1957-1959.
[12]高佳敏,王涛,朱云峰,等.尿酸/高密度脂蛋白胆固醇比值对2型糖尿病合并非酒精性脂肪性肝病的预测价值[J].陕西医学杂志,2025,54(3):323-327.
[13]黄蕾,周锋.胰岛素抵抗代谢评分与缺血性脑卒中的研究进展[J].陕西医学杂志,2025,54(1):142-145.
[14]KOUNTOURAS J,PAPAEFTHYMIOU A,POLYZOS S A,et al.Potential impact of helicobacter pylori-related metabolic syndrome on arterial hypertension outcomes[J].Am J Hypertens,2023,36(4):192-194.
[15]KOUNTOURAS J,DOULBERIS M,POLYZOS S A,et al.Impact of helicobacter pylori-related metabolic syndrome with hyperhomocysteinemia on extragastric pathologies[J].J Gastroenterol Hepatol,2022,37(2):407-408.
[16]董佳鑫,王海艳,喀麦隆,等.幽门螺杆菌感染致表皮生长因子及其受体表达上调与胃癌发生及发展机制关系研究进展[J].陕西医学杂志,2024,53(6):853-857.
[17]钟爽,罗慧,施智兰,等.胆汁酸、幽门螺旋杆菌等因素诱导尾型同源盒转录因子2表达致胃黏膜肠上皮化生研究进展[J].陕西医学杂志,2023,52(6):771-774.
[18]XIAO Q Y,WANG R L,WU H J,et al.Effect of helicobacter pylori infection on glucose metabolism,lipid metabolism and inflammatory cytokines in nonalcoholic fatty liver disease patients[J].J Multidiscip Healthc,2024,17:1127-1135.
[19]张家祥,周永学,闫曙光,等.缺氧诱导的线粒体自噬与糖代谢重编程对胃癌前病变影响的研究进展[J].中国癌症杂志,2022,32(10):1007-1015.
[20]张晓玲,黄莹芝.2型糖尿病患者血清C1q/肿瘤坏死因子相关蛋白12水平与颈动脉粥样硬化相关性的研究[J].中国糖尿病杂志,2025,33(2):109-113.
[21]BABEL R A,DANDEKAR M P.A review on cellular and molecular mechanisms linked to the development of diabetes complications[J].Curr Diabetes Rev,2021,17(4):457-473.
[22]安冬,翟艳会,高艳奎,等.大黄黄连泻心汤及其加减方改善2型糖尿病研究进展[J].中国实验方剂学杂志,2024,30(24):141-151.
[23]吕永乐,郑雯,王签慧,等.抗代谢相关脂肪性肝病的天然活性物质研究进展[J].畜牧兽医学报,2025,56(1):45-62.
[24]曾佳玲,蒙艳,邓婷婷,等.2型糖尿病患者非酒精性脂肪肝与内脏脂肪面积及甲状腺结节的相关性研究[J].中国全科医学,2025,28(9):1072-1083.
[25]陈京京,陈盈玲,单浩杰,等.2型糖尿病患者连续血糖监测目标范围内时间与血清骨钙素N端中分子片段、Ⅰ型前胶原氨基端前肽相关性研究[J].陕西医学杂志,2025,54(3):319-327.
[26]ARON WISNEWSKY J,WARMBRUNN M V,NIEUWDORP M,et al.Metabolism and metabolic disorders and the microbiome:The intestinal microbiota associated with obesity,lipid metabolism,and metabolic health-pathophysiology and therapeutic strategies[J].Gastroenterology,2021,160(2):573-599.